hesperidin has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El Motteleb, DM; Elshazly, SM; Ibrahim, IAAE | 1 |
| Dong, W; Du, J; Huang, C; Liu, S; Qu, X; Wang, Y; Yan, T | 1 |
2 other study(ies) available for hesperidin and Disease Exacerbation
| Article | Year |
|---|---|
Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats.
Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; Body Weight; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Disease Progression; Hesperidin; Hydrogen-Ion Concentration; Insulin; Leukocyte Common Antigens; Male; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Omeprazole; Oxidants; PPAR gamma; Protective Agents; Rats, Wistar; Stomach; Stomach Ulcer; Stress, Physiological; Tumor Necrosis Factor-alpha | 2018 |
Combination of hesperetin and platinum enhances anticancer effect on lung adenocarcinoma.
Topics: A549 Cells; Adenocarcinoma of Lung; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Disease Progression; Glucuronosyltransferase; Hesperidin; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Platinum Compounds; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2019 |